跳至主要内容
临床试验/NCT00430053
NCT00430053已完成不适用

Pathogenesis And Course Of Cutaneous T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Disease course of patients with cutaneous T-cell lymphoma (CTCL)

研究概览

简要总结

RATIONALE: Gathering information about patients with cutaneous T-cell lymphoma over time may help doctors learn more about the disease.

PURPOSE: This natural history study is collecting disease-related health information over time from patients with cutaneous T-cell lymphoma.

详细描述

OBJECTIVES:

Primary

  • Follow the disease course of patients with cutaneous T-cell lymphoma.
  • Provide a patient population for study by proteomic and molecular analysis.
  • Develop a mechanism for screening by a Tumor Board for enrollment of patients in therapeutic clinical trials.

Secondary

  • Develop a tissue bank for future disease study using specimens from these patients.
  • Provide community outreach by offering a second opinion regarding treatment of this disease in these patients and, in limited cases, provide standard-of-care treatment to these patients.
  • Develop an algorithm for screening and evaluating this disease in these patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Disease course of patients with cutaneous T-cell lymphoma (CTCL)

Provide a patient population for study by proteomic and molecular analysis

Mechanism for screening by a Tumor Board for enrollment of patients in therapeutic clinical trials

次要结局

  • Develop a tissue bank for future disease study
  • Offer a second opinion regarding treatment of CTCL and, in limited cases, provide standard-of-care treatment
  • Develop an algorithm for screening and evaluating CTCL

研究者

研究点 (1)

Loading locations...

相似试验